Algernon Announces 75% Enrollment in Multinational Phase 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 Biotech Investing
AbbVie to Present New Data From 15 Abstracts at the 2020 Virtual Migraine Trust International Symposium Biotech Investing
UNCF, Bristol Myers Squibb Announce Second Cohort of the Ernest E. Just Postgraduate Fellowship and Extension of Partnership Through 2026 Biotech Investing
 Bristol Myers Squibb to Host Virtual Investor Event to Discuss Results from Phase 3 True North Trial Evaluating Zeposia® in Ulcerative Colitis at UEG Week 2020 Biotech Investing
Gilead Sciences Update on Supply and Distribution of Veklury® in the United States Biotech Investing
Public coverage of AbbVie's SKYRIZI® for the treatment of Moderate to Severe Plaque Psoriasis is now available across additional jurisdictions Biotech Investing
Gilead Sciences Presents Data From HIV Research and Development Programs at HIV Glasgow 2020 Biotech Investing
Algernon Announces Enrollment of 100 Patients in Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 Biotech Investing
Health Canada Approves REBLOZYL® , New Class of Treatment for Adult Patients Living with Beta Thalassemia Biotech Investing
